What are the medications used to treat chronic migraine?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 27, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Medications for Chronic Migraine

For chronic migraine (≥15 headache days per month), topiramate is the first-line preventive medication, followed by onabotulinumtoxinA if topiramate fails, and then CGRP monoclonal antibodies as third-line therapy after failure of at least two other preventive medications. 1, 2

Critical Diagnostic Prerequisite

  • Rule out medication overuse headache (MOH) before initiating any preventive therapy, as MOH frequently mimics chronic migraine and will prevent response to preventive medications 1, 2
  • MOH occurs when acute medications are used ≥10 days per month and requires withdrawal of overused medications before starting preventive treatment 3, 2

Acute Treatment Medications (Limited Use)

Acute medications must be strictly limited to no more than twice weekly to prevent medication overuse headache 1, 2

First-Line Acute Treatment

  • NSAIDs: aspirin, ibuprofen, naproxen sodium, or diclofenac potassium 1, 2
  • Combination agent: acetaminophen plus aspirin plus caffeine 1
  • Antiemetics: domperidone or metoclopramide when nausea/vomiting is present 1, 2

Second-Line Acute Treatment (When NSAIDs Fail)

  • Triptans: naratriptan, rizatriptan, zolmitriptan, or sumatriptan (oral or subcutaneous) 1, 4, 5
  • DHE nasal spray 1
  • Lasmiditan (selective 5HT1F receptor agonist) 6
  • CGRP receptor antagonists (gepants) 6

Medications to Avoid

  • Ergot alkaloids, opioids, and barbiturates should be avoided due to questionable efficacy and high risk of dependency and medication overuse headache 2

Preventive Medications: Algorithmic Approach

First-Line Preventive Medications

Topiramate is the drug of first choice due to proven efficacy in chronic migraine and much lower cost compared to biologics 1, 2

  • Topiramate: 100 mg/day (titrate gradually from low dose) 1, 2, 7
    • Particularly beneficial in obese patients due to weight loss effect 1, 3
    • May take 2-3 months to see clinical benefit 1

Alternative first-line options (though evidence is stronger for episodic migraine than chronic migraine):

  • Beta-blockers: propranolol (80-240 mg/day), timolol (20-30 mg/day), atenolol, bisoprolol, or metoprolol 1, 8, 7
    • Note: Propranolol increases rizatriptan levels by 70%, requiring dose adjustment 5
  • Candesartan 1, 7, 9

Second-Line Preventive Medications

If topiramate fails or is not tolerated:

  • Amitriptyline: 30-150 mg/day 1, 7, 10, 9
    • Particularly beneficial for patients with depression or sleep disturbances 1
  • Flunarizine: 10 mg/day (where available) 1
    • Adverse events include sedation, weight gain, depression, and extrapyramidal symptoms in elderly 1
  • Divalproex sodium/sodium valproate: 500-1500 mg/day or 800-1500 mg/day 1, 7, 11, 10
    • Strictly contraindicated in women of childbearing potential 1

Third-Line Preventive Medications

OnabotulinumtoxinA is indicated after topiramate and at least one other preventive medication have failed 1, 2, 7

  • Efficacy should be assessed only after 6-9 months 1
  • FDA-approved specifically for chronic migraine prevention 7, 9

CGRP monoclonal antibodies are reserved for patients who have failed at least two or three other preventive medications due to regulatory restrictions and high cost 1, 2

  • Erenumab, fremanezumab, and galcanezumab have proven benefit in patients who failed multiple preventive medications 1, 9, 6
  • Eptinezumab is also available 1
  • Efficacy should be assessed only after 3-6 months 1

Medications with Limited Evidence for Chronic Migraine

No robust data from randomized controlled trials support the use of beta-blockers, candesartan, or amitriptyline specifically for chronic migraine, although they are commonly used in clinical practice 1

Non-Pharmacological Preventive Therapies

These can be used as adjuncts or stand-alone treatments when medications are contraindicated:

  • Cognitive-behavioral therapy (CBT) 1, 2, 9
  • Biofeedback 1, 2, 9
  • Relaxation training 1, 2, 9
  • Regular exercise: 40 minutes three times weekly (as effective as topiramate) 3, 2
  • Neuromodulatory devices 1, 2
  • Acupuncture 1

Nutraceuticals with Fair Evidence

  • Magnesium citrate 1, 9
  • Riboflavin 1, 9
  • Coenzyme Q10 9
  • Feverfew 1

Critical Management Principles

  • Start preventive medications at low doses and titrate slowly until clinical benefits are achieved or limited by adverse events 1
  • Allow adequate trial period: 2-3 months for oral medications, 3-6 months for CGRP antibodies, 6-9 months for onabotulinumtoxinA 1
  • Avoid interfering medications such as overused acute medications during preventive treatment 1
  • Consider pausing preventive therapy after 6-12 months of stability to determine if treatment can be stopped 1
  • Address comorbidities (depression, anxiety, sleep disorders, obesity, chronic pain) as their management directly improves migraine outcomes 1, 3, 2

Common Pitfalls to Avoid

  • Do not initiate preventive therapy without first ruling out and treating MOH 2
  • Do not allow unlimited acute medication use - strict limitation to twice weekly prevents progression 2
  • Do not abandon treatment prematurely - efficacy may take 2-3 months to manifest 1
  • Do not use valproate in women of childbearing potential 1

When to Refer to Specialist

  • Confirmed chronic migraine diagnosis 2
  • Failure of multiple preventive medications 2
  • Consideration of onabotulinumtoxinA or CGRP antibodies 2
  • Diagnostic uncertainty 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Chronic Migraine Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Migraine Risk Factors and Prevention

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Migraine.

Nature reviews. Disease primers, 2022

Research

Preventive Therapy of Migraine.

Continuum (Minneapolis, Minn.), 2018

Research

Preventive migraine treatment.

Neurologic clinics, 2009

Research

Preventive treatment of migraine: an overview.

Cephalalgia : an international journal of headache, 1997

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.